← Leaderboards
En Li
Massachusetts General Hospital
$2,750,799
Attributed
$2,750,799
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,750,799 · 3
By mechanism
R01$2,750,799 · 3
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jan L Christian$11,530,457
- Jodie L Babitt$8,318,929
- Paul B Yu$13,557,400
- Jeannie T Lee$25,305,477
- Herbert Y Lin$7,187,681
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingGenetically Modified AnimalsLaboratory MouseCell ProliferationCell Growth RegulationGene ExpressionMammalian EmbryologyDna MethylationDevelopmental GeneticsMethyltransferaseIn Situ HybridizationFlow CytometryEnzyme ActivityEnzyme StructureGenomic ImprintingFluorescent In Situ HybridizationNorthern BlottingsPolymerase Chain ReactionSex ChromosomesSouthern BlottingTransforming Growth FactorsImmunocytochemistryAthymic MouseBiological Signal Transduction
Grant awards (10)
DNA METHYLATION AND MAMMALIAN DEVELOPMENT$322,815
R01 · FY2004 · GM
DNA METHYLATION AND MAMMALIAN DEVELOPMENT$322,815
R01 · FY2003 · GM
DNA METHYLATION AND MAMMALIAN DEVELOPMENT$322,815
R01 · FY2002 · GM
ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION$265,583
R01 · FY2002 · HD
DE NOVO METHYLTRANSFERASES AND CANCER$235,302
R01 · FY2002 · CA
DNA METHYLATION AND MAMMALIAN DEVELOPMENT$322,815
R01 · FY2001 · GM
ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION$257,848
R01 · FY2001 · HD
DE NOVO METHYLTRANSFERASES AND CANCER$223,583
R01 · FY2001 · CA
ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION$250,341
R01 · FY2000 · HD
DE NOVO METHYLTRANSFERASES AND CANCER$226,882
R01 · FY2000 · CA